Skip to content
  • About Us
    • Careers
  • Services
    • Buy Side Advisory
    • Capital Raising
    • Sell Side Advisory
    • Transaction Planning & Readiness Review
  • Industry Expertise
    • Business Services & Technology
    • Consumer, Food & Retail
    • Healthcare
    • Industrials
    • Plastics & Packaging
  • Transactions
  • Team
  • News & Insights
    • Events
    • Industry Updates
    • News
    • Perspectives
Menu
  • About Us
    • Careers
  • Services
    • Buy Side Advisory
    • Capital Raising
    • Sell Side Advisory
    • Transaction Planning & Readiness Review
  • Industry Expertise
    • Business Services & Technology
    • Consumer, Food & Retail
    • Healthcare
    • Industrials
    • Plastics & Packaging
  • Transactions
  • Team
  • News & Insights
    • Events
    • Industry Updates
    • News
    • Perspectives
Contact

Industry Updates

  • Back to News & Insights

Medical Technology M&A Pulse – Q2 2022

  • August 30, 2022
  • Industry Updates
  • Healthcare, Medical Technology
1H 2022: Growing Market Uncertainty
  • The second quarter was defined by general sense of uncertainty in the market, as concerns about inflation and rising interest rates dominated headlines
  • On top of the economic factors impacting the market, major geopolitical issues continue to add uncertainty. The conflict between Russia and Ukraine continues to shape geopolitical discourse, while periodic outbreaks of COVID apply strain on the healthcare system. Public equity markets reflected this negative sentiment with an underwhelming second quarter, but middle market M&A transactions have not been impacted to the same extent.
  • Despite market concerns, 2022 Q2 M&A transaction volume remained strong, with a robust 28% increase from Q1. The total deal volume of 299 transactions for the first half of the year is higher than the 2017-2020 average. Activity levels can be attributed to record amounts of private equity dry powder and appetite for high quality assets that can perform in a volatile market.
  • During the first half of the year, PMCF’s four tracked medical subsector indices all outperformed the benchmark S&P 500 Growth Index, which was down 28.5%, and two of the indices outperformed the Dow Jones Industrial Average, which was down 15.9%.

 

Read Medical Technology M&A Pulse Q2 2022 Full Report

Download Preview

Stay Informed

Subscribe to our newsletter for the latest industry updates

Subscribe

Recent Publications

Human Capital Management M&A Pulse – Q4 2022
Plastics M&A Update – November 2022
Packaging M&A Update – November 2022
Industrial Distributor M&A Pulse – Q3 2022
Food & Beverage M&A Pulse – Q3 2022
Contact

Follow Us On

Cfi Logo White 94x94 On About

Home

  • About
  • Team
  • Careers

Services

  • Buy Side Advisory
  • Capital Raising
  • Sell Side Advisory
  • Transaction Planning & Readiness Review

Industry Expertise

  • Business Services & Technology
  • Consumer, Food & Retail
  • Healthcare
  • Industrials
  • Plastics & Packaging

News & Insights

  • Transactions
  • News
  • Industry Updates
  • Perspectives
  • Events

PMCF is a trade name for PMCF Advisors, LLC and P&M Corporate Finance, LLC. The term “PMCF” refers to one or more of these legally separate and independent advisory practices. P&M Corporate Finance, LLC provides capital raising and private placement services that require registration as a broker-dealer.

©2022 PMCF

  • Member SIPC​
  • Member FINRA
  • FINRA Broker Check
  • Business Continuity Plan​
  • Disclaimer​
  • Privacy Policy​